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Background: While high-intensity statin therapy can regress coronary atheroma, serial effects on coronary plaque composition remain unknown.
methods: SATURN employed serial intravascular ultrasound (IVUS) measures of coronary atheroma in patients treated with rosuvastatin 40 mg 
or atorvastatin 80 mg daily for 24-months. Seventy-one patients underwent serial assessment of plaque composition by spectral analysis of the 
radiofrequency IVUS signal.
results: Changes in LDL-C [-52 mg/dL (-72, -33), p<0.001], CRP [-0.2 mg/L (-1, 0.1), p=0.01] and HDL-C [+2.8 mg/dL (-0.3, 7.8), p<0.001] 
associated with regression of percent atheroma volume (PAV) [-1.8% (-3.6, 0.33), p<0.001]. A reduction in estimated fibro-fatty (FF) tissue volume 
accompanied atheroma regression, (p<0.001), while dense calcium (DC) tissue volume increased (p=0.002) (Table). Volumetric changes in necrotic 
core (NC) tissue correlated with on-treatment HDL-C (r = -0.27, p=0.03) and CRP (r = 0.25, p=0.03) levels. A per lesion analysis showed a reduction 
in the number of pathological intimal thickening lesions (defined by ≥3 consecutive IVUS frames containing PAV ≥40%, predominantly FF plaque, 
with <10% confluent NC and <10% confluent DC) at follow-up (67 vs. 38, p=0.001).
conclusions: Changes in indices of atheroma composition, consistent with plaque stabilization, accompany regression of coronary atheroma with 
high-intensity statin therapy, and associate with anti-inflammatory effects of statins. 
Grey-scale and RF-IVUS data (vessel level analysis)
Volumetric parameter Baseline Follow-up Change P-value
PAV (%)
38.5
(34, 46.5)
37.7
(33, 44)
-1.8
(-3.6, 0.33)
<0.001
Change Fibrous (mm3)
18.5
(9.8, 29.3)
16.5
(5.9, 24.6)
-2.2
(-9.0, 2.1)
<0.001
Change Fibro-fatty (mm3)
23.1
(8.8, 36.3)
13.4
(5.1, 28)
-4.8
(-14.9, -0.21)
<0.001
Change Dense calcium (mm3)
1.2
(0.2, 3.8)
2.1
(0.3, 4)
0.32
(-0.15, 1.2)
0.002
Change Necrotic core (mm3)
5.9
(2.6, 12.3)
6
(2.3, 12.4)
0.09
(-1.2, 1.9)
0.84
% Change Fibrous
39
(32.7, 51.1)
40.3
(32.2, 49.8)
1.7
(-6.1, 7.4)
0.38
% Change Fibro-fatty
41.3
(31.5, 52.3)
36.6
(25.6, 47.5)
-5.2
(-14.6, 3.6)
0.002
% Change Dense calcium
2.1
(1.0, 7.0)
4.5
(1.6, 8.0)
1.2
(-0.03, 3.5)
<0.001
% Change Necrotic core
12.6
(8.2, 17.4)
15.5
(11.1, 19.3)
1.9
(-0.44, 6.0)
<0.001
